Literature DB >> 9362465

Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit.

A C Missias1, J Mudd, J M Cunningham, J H Steinbach, J P Merlie, J R Sanes.   

Abstract

At many synapses, 'fetal' neurotransmitter receptor subunits are replaced by 'adult' subunits as development proceeds. To assess the significance of such transitions, we deleted the gene encoding the adult acetylcholine receptor (AChR) epsilon subunit, which replaces its fetal counterpart, the gamma subunit, at the skeletal neuromuscular junction during early postnatal life. Several aspects of postnatal maturation, including synapse elimination, proceeded normally in the absence of the adult AChR, but structural development of the endplate was compromised. Later, inadequate compensation by the gamma subunit led to severely reduced AChR density in mutant endplates relative to controls. This decreased density led to a profound reorganization of AChR-associated components of the postsynaptic membrane and cytoskeleton. Together, these results suggest novel roles for AChRs in assembly of the postsynaptic apparatus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362465     DOI: 10.1242/dev.124.24.5075

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  27 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 3.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

4.  Active zone density is conserved during synaptic growth but impaired in aged mice.

Authors:  Jie Chen; Takafumi Mizushige; Hiroshi Nishimune
Journal:  J Comp Neurol       Date:  2012-02-01       Impact factor: 3.215

5.  Spontaneous muscle action potentials fail to develop without fetal-type acetylcholine receptors.

Authors:  Masazumi Takahashi; Tai Kubo; Akira Mizoguchi; C George Carlson; Katsuaki Endo; Katsunori Ohnishi
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

Review 6.  Molecular mechanism of active zone organization at vertebrate neuromuscular junctions.

Authors:  Hiroshi Nishimune
Journal:  Mol Neurobiol       Date:  2011-12-02       Impact factor: 5.590

Review 7.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

8.  The knockdown of αkap alters the postsynaptic apparatus of neuromuscular junctions in living mice.

Authors:  Isabel Martinez-Pena Y Valenzuela; Mohamed Aittaleb; Po-Ju Chen; Mohammed Akaaboune
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 9.  Processing of ARIA and release from isolated nerve terminals.

Authors:  B Han; G D Fischbach
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

10.  Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit.

Authors:  Katrin Hoffmann; Juliane S Muller; Sigmar Stricker; Andre Megarbane; Anna Rajab; Tom H Lindner; Monika Cohen; Eliane Chouery; Lynn Adaimy; Ismat Ghanem; Valerie Delague; Eugen Boltshauser; Beril Talim; Rita Horvath; Peter N Robinson; Hanns Lochmüller; Christoph Hübner; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2006-06-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.